Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients

[1]  M. Walter,et al.  Increased clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation , 2023, JCI insight.

[2]  J. Dick,et al.  Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  Nicholette D. Palmer,et al.  Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential , 2022, Science advances.

[4]  Andrew D. Johnson,et al.  Clonal Hematopoiesis Is Associated With Higher Risk of Stroke , 2021, Stroke.

[5]  D. Link,et al.  Increased Incidence of Clonal Hematopoiesis in Lung Transplant Recipients Involves DNA Damage Response Genes , 2021, Blood.

[6]  Sina A. Gharib,et al.  Association of clonal hematopoiesis with chronic obstructive pulmonary disease , 2021, Blood.

[7]  Matthew S. Lebo,et al.  Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection , 2021, Nature Medicine.

[8]  A. Bick,et al.  Germline risk of clonal haematopoiesis , 2021, Nature Reviews Genetics.

[9]  A. Dopazo,et al.  Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction. , 2021, Journal of the American College of Cardiology.

[10]  P. Awadalla,et al.  Clonal hematopoiesis is associated with risk of severe Covid-19 , 2020, Nature Communications.

[11]  A. Zeiher,et al.  Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations. , 2020, European heart journal.

[12]  M. Neely,et al.  Risk factors for mortality in lung transplant recipients aged ≥65 years: A retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  Ivana V. Yang,et al.  Inherited Causes of Clonal Hematopoiesis in 97,691 TOPMed Whole Genomes , 2020, Nature.

[14]  A. Zeiher,et al.  Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. , 2020, JAMA cardiology.

[15]  W. Tapper,et al.  Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking , 2020, Leukemia.

[16]  Lisa M Haley,et al.  Cancer spectrum and outcomes in the Mendelian short telomere syndromes. , 2020, Blood.

[17]  Kristian Cibulskis,et al.  Calling Somatic SNVs and Indels with Mutect2 , 2019, bioRxiv.

[18]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  D. Goldstein,et al.  Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants. , 2019, Chest.

[20]  Liying Zhang,et al.  Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis. , 2019, Blood advances.

[21]  P. Libby,et al.  Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease , 2019, Nature Reviews Cardiology.

[22]  Brian E. Cade,et al.  Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program , 2019, Nature.

[23]  B. Brüne,et al.  Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure , 2018, JAMA cardiology.

[24]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  K. Walsh,et al.  CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease , 2018, Circulation research.

[26]  D. Goukassian,et al.  Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. , 2018, Journal of the American College of Cardiology.

[27]  Kari Stefansson,et al.  Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.

[28]  P. Corris,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  Christian Gilissen,et al.  Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life. , 2017, American journal of human genetics.

[30]  D. Goldstein,et al.  An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis , 2017, American journal of respiratory and critical care medicine.

[31]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[32]  J. Belperio,et al.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction , 2017, The Journal of clinical investigation.

[33]  Matthew A. Cooper,et al.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.

[34]  C. Balestrieri,et al.  Dnmt3a restrains mast cell inflammatory responses , 2017, Proceedings of the National Academy of Sciences.

[35]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[36]  Xia Li,et al.  Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 , 2015, Nature.

[37]  S. Verleden,et al.  Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[38]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[39]  G. Verleden,et al.  Differential Cytokine, Chemokine and Growth Factor Expression in Phenotypes of Chronic Lung Allograft Dysfunction , 2015, Transplantation.

[40]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[41]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[42]  G. Verleden,et al.  An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome , 2014, European Respiratory Journal.

[43]  L. Snyder,et al.  Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction. , 2014, American journal of respiratory and critical care medicine.

[44]  L. Snyder,et al.  Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients. , 2013, Chest.

[45]  D. Schwartz,et al.  Genetic Regulation of Rejection and Survival Following Human Lung Transplantation by the Innate Immune Receptor CD14 , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[46]  Gerald J Berry,et al.  Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[47]  D. Schwartz,et al.  Innate immunity influences long-term outcomes after human lung transplant. , 2005, American journal of respiratory and critical care medicine.

[48]  L. Snyder,et al.  Lung transplantation at Duke University Medical Center. , 2007, Clinical transplants.